Hematologists Consider Where New Therapies Fit In Sickle Cell Treatment Paradigm
Potential Cures May Not Be Available To All
The first gene editing medicine and gene therapy for sickle cell disease were approved as the ASH meeting got under way, but novel oral drugs may be key to making treatment more accessible.
